Reed Tech company Revenue and Competitors

Horsham, PA USA

Location

N/A

Total Funding

Technology

Industry

Estimated Revenue & Valuation

  • Reed Tech company's estimated annual revenue is currently $98.2M per year.(i)
  • Reed Tech company's estimated revenue per employee is $252,500

Employee Data

  • Reed Tech company has 389 Employees.(i)
  • Reed Tech company grew their employee count by -9% last year.

Reed Tech company's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
Chief ArchitectReveal Email/Phone
3
Director, Network Infrastructure & OperationsReveal Email/Phone
4
Director Product Management - Medical Devices Product SuiteReveal Email/Phone
5
Senior Director, Business Planning & AnalysisReveal Email/Phone
6
Director, Life Sciences SalesReveal Email/Phone
7
Sr Director Human ResourcesReveal Email/Phone
8
Director Software EngineeringReveal Email/Phone
9
Head IT Infrastructure and Operations; Director Systems EngineeringReveal Email/Phone
10
Director, ProductionReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.5M50%N/AN/A
#2
$1.8M157%N/AN/A
#3
$0.7M70%N/AN/A
#4
$7.1M440%N/AN/A
#5
$0.5M50%N/AN/A
#6
$1.5M120%N/AN/A
#7
$1.8M157%N/AN/A
#8
$45.8M206-24%N/AN/A
#9
$2880.3M10185N/AN/AN/A
#10
$2.2M180%N/AN/A
Add Company

What Is Reed Tech company?

Reed Technology has the experience, qualifications and capacity to perform your label conversions at the highest levels of accuracy and quality, whether you have one label or hundreds. Reed Tech's pharmaceutical industry document conversion experience includes successful conversion of over 2,000 SPL labels to date, including Physician Labeling Rule (PLR) conversions. Reed Tech is also a leading provider of both SPL and SPL-PLR consulting services. Our customers include 6 of the world's top 10 largest pharmaceutical manufacturers, some with over a hundred labels. Our customers also include smaller firms, each with a single label to manage. This experience benefits pharmaceutical manufacturers who will be providing PIM compliant documents in the future. No matter the volume of your need, Reed Tech has the knowledge, experience and resources to provide quality results. You most likely already know of Reed Tech, even if you do not know us by name. For over 37 years, we have been performing high-volume, high-accuracy conversions of patent applications and patent grants to XML for the U.S. Patent and Trademark Office (USPTO) and other customers. We deliver over 400,000 XML-converted documents to the USPTO annually. The XML- and image-based patent information products that we deliver to the USPTO are used by USPTO examiners and staff internally and disseminated worldwide. Reed Tech is a business unit of Reed Elsevier, one of the largest publishers and information solution providers in the world. We are a sister company to Elsevier, a world leader in technical, scientific and medical data aggregation and publication.

keywords:N/A

N/A

Total Funding

389

Number of Employees

$98.2M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Reed Tech company News

2022-04-20 - Netflix Is Open to a Lower Price Tier -- With Ads

Co-CEO Reed Hastings discussed the potential change during the company's ... the company's goal is to bring more value to subscribers while...

2022-04-20 - Netflix will launch lower-cost, ad-supported streaming plans

... finally open to experimenting with lower-cost, ad-supported packages, co-CEO Reed Hastings said on the company's Q1 earnings interview.

2021-09-21 - Achieving Compliance: Pharma Annual Deadlines, Upcoming Webinar Hosted by Xtalks

This webinar will unpack and explain each of these deadlines and how to submit. TORONTO (PRWEB) September 21, 2021 Join us for this live event featuring Reed Tech subject matter experts Gary Saner and David Wilson for a complete look at the annual deadlines that pharmaceutical companies are re ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1890M438-5%N/A
#2
N/A4963%N/A
#3
$35M522-6%N/A
#4
$105.5M525N/AN/A
#5
$178.9M5302%N/A